PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Ophthalmology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.\', \'Deparment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.\', \'Sydney Eye Hospital, Sydney University, Sydney, NSW, Australia.\', \'Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.\', \'Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA.\', \'International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, China.\', \'C-MER Dennis Lam Eye Centre, C-MER International Eye Care Group Limited, Hong Kong SAR, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/APO.0000000000000289
?:doi
?:hasPublicationType
?:journal
  • Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
is ?:pmid of
?:pmid
?:pmid
  • 32349115
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19.
?:type

Metadata

Anon_0  
expand all